UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
______________
FORM 8-K
______________
Current
Report
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of
Report (Date of earliest event reported): January 3, 2019 (January 3,
2019)
______________
MOLINA
HEALTHCARE, INC.
(Exact
name of registrant as specified in its charter)
|
Delaware |
1-31719 |
13-4204626 |
|
(State or other jurisdiction of |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
______________
|
200 Oceangate, Suite 100, Long Beach, California 90802 |
|
(Address of principal executive offices) |
Registrant’s telephone number, including area code: (562) 435-3666
Check the
appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:
⃞ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
⃞ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
⃞ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
⃞ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter)
|
Emerging growth company |
⃞ |
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. |
⃞ |
Item 7.01. Regulation FD Disclosure.
On January 3, 2019, Molina Healthcare, Inc. announced that it has extended its agreement with CVS Caremark for pharmacy benefit management (PBM) services through 2021. A copy of the press release is attached hereto as Exhibit 99.1.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits:
|
Exhibit |
|
| No. |
Description |
|
99.1 |
Press release dated January 3, 2019. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
MOLINA HEALTHCARE, INC. |
||||
|
|
||||
| Date: | January 3, 2019 | By: |
/s/ Jeff D. Barlow |
|
|
|
Jeff D. Barlow |
|||
|
|
Chief Legal Officer and Secretary |
|||
EXHIBIT INDEX
|
Exhibit |
|
| No. | Description |